viewNaturally Splendid Enterprises Ltd.

Full interview: Naturally Splendid gets guidance from Health Canada as Biologic begins Phase 2 clinical trial

Naturally Splendid (CVE: NSP- OTC: NSPDF) partner Biologic Pharmamedical CEO Franco Cavaleri joined Steve Darling from Proactive Vancouver with news the company has received word back from Health Canada that the Biologics division will be one of the divisions of Health Canada handling this study.

Cavaleri also told Proactive, the trial will begin as a Phase 2 study and after an interim analysis is performed on the first 40 patients, the data will determine the number of expected patients needed to reach statistical significance in a Phase 3 study.

Quick facts: Naturally Splendid Enterprises Ltd.

Price: 0.065 CAD

Market: TSX-V
Market Cap: $11.98 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Naturally Splendid Enterprises Ltd. named herein, including the promotion by the Company of Naturally Splendid Enterprises Ltd. in any Content...


Naturally Splendid passes audit to maintain its Safe Quality Food Level 2...

Naturally Splendid (CVE: NSP-OTC: NSPDF) CEO Craig Goodwin joined Steve Darling from Proactive Vancouver to discuss the company once again passing their annual audit that certifies their Pitt Meadows, BC operation as a Safe Quality Food Level 2 certified food manufacturing facility. Goodwin...

on 8/7/20

2 min read